The ABCs of JAKis: A Clinician's Guide to Safety and Monitoring of the Systemic JAK Inhibitors
Recommended Citation
Sodha D, Lio P, and Gold LS. The ABCs of JAKis: A Clinician's Guide to Safety and Monitoring of the Systemic JAK Inhibitors. J Drugs Dermatol 2024; 23(10):856.
Document Type
Article
Publication Date
10-1-2024
Publication Title
Journal of drugs in dermatology : JDD
Abstract
Janus kinase inhibitors (JAKis) have recently emerged in the arsenal of tools to treat dermatological conditions. However, there are some concerns regarding these treatments due to their boxed warning. Here we discuss the safe and effective use of JAKs for the treatment of a wide variety of dermatologic conditions. We will also discuss monitoring guidelines.
Medical Subject Headings
Humans; Drug Monitoring; Janus Kinase Inhibitors; Practice Guidelines as Topic; Skin Diseases
PubMed ID
39361691
Volume
23
Issue
10
First Page
856
Last Page
856
COinS
